Adelaide Research & Scholarship: Search

Search

Results 1-8 of 8 (Search time: 0.002 seconds).

previous
1
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2014	Discovery of a novel site of opioid action at the innate immune pattern-recognition receptor TLR4 and its role in addiction	Jacobsen, J.; Watkins, L.; Hutchinson, M.; Cui, C.; Shurtleff, D.; Harris, R.A.
	2014	Glial TLR4 signaling does not contribute to opioid-induced depression of respiration	Zwicker, J.; Zhang, Y.; Ren, J.; Hutchinson, M.; Rice, K.; Watkins, L.; Greer, J.; Funk, G.
	2015	Alcohol-induced sedation and synergistic interactions between alcohol and morphine: a key mechanistic role for Toll-like receptors and MyD88-dependent signaling	Corrigan, F.; Wu, Y.; Tuke, J.; Coller, J.; Rice, K.; Diener, K.; Hayball, J.; Watkins, L.; Somogyi, A.; Hutchinson, M.
	2013	Glucuronic acid and the ethanol metabolite ethyl-glucuronide cause toll-like receptor 4 activation and enhanced pain	Lewis, S.; Hutchinson, M.; Zhang, Y.; Hund, D.; Maier, S.; Rice, K.; Watkins, L.
	2013	Effect of chronic delivery of the toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving	Theberge, F.; Li, X.; Kambhampati, S.; Pickens, C.; St Laurent, R.; Bossert, J.; Baumann, M.; Hutchinson, M.; Rice, K.; Watkins, L.; Shaham, Y.
	2012	Commentary on Landry et al.: "Propentofylline, a CNS glial modulator, does not decrease pain in post-herpetic neuralgia patients: in vitro evidence for differential responses in human and rodent microglia and macrophages"	Watkins, L.; Hutchinson, M.; Johnson, K.
	2012	(+)-Naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats	Lewis, S.; Loram, L.; Hutchinson, M.; Li, C.; Zhang, Y.; Maier, S.; Huang, Y.; Rice, K.; Watkins, L.
	2015	Select steroid hormone glucuronide metabolites can cause toll-like receptor 4 activation and enhanced pain	Lewis, S.; Hutchinson, M.; Frick, M.; Zhang, Y.; Maier, S.; Sammakia, T.; Rice, K.; Watkins, L.